Archives

Luma Health Buys Tonic Health To Streamline Patient Care For Over 1,000 Health Systems And 100 Million Patients

By Amit Chowdhry ● Nov 12, 2025

Luma Health has announced the acquisition of Tonic Health from R1, marking a significant expansion in its mission to simplify and automate patient care. Tonic Health is a leading provider of dynamic intake, electronic consent, and patient-reported outcome solutions. The move strengthens Luma’s capabilities in patient intake and follow-up, while reinforcing its commitment to health systems that use Oracle Health EHRs.

QorusDocs: Interview With CEO Ray Meiring About The Automated Proposal And RFP Response Company

By Amit Chowdhry ● Nov 12, 2025

QorusDocs provides AI-powered proposal and RFP response software to help organizations create faster, more consistent revenue documents. Pulse 2.0 interviewed QorusDocs CEO Ray Meiring to gain a deeper understanding of the company.

SPIE Acquires Majority Stake in PIK AG to Strengthen Audiovisual Systems Expertise Across Germany

By Amit Chowdhry ● Nov 12, 2025

SPIE, the independent European leader in multi-technical services across energy infrastructure and communications, announced the signing of an agreement to acquire 89% of PIK AG, a Berlin-based company specializing in audiovisual integration and maintenance.

DataCamp Buys Optima To Build The AI Learning Engine Of The Future

By Amit Chowdhry ● Nov 12, 2025

DataCamp, the leading online learning platform for data and AI skills, has announced the acquisition of Optima, a Dubai-based AI-native learning platform designed to personalize data and AI education. The deal marks a significant step in DataCamp’s strategy to expand its AI-driven learning capabilities while accelerating its path toward crossing $100 million in annualized recurring revenue (ARR) by 2026.

Leukogene Therapeutics Secures Strategic Funding From South Carolina Research Authority To Advance Cancer Immunotherapy Pipeline

By Amit Chowdhry ● Nov 12, 2025

Leukogene Therapeutics, a biopharmaceutical company developing next-generation therapies for hematologic and other immunologically “cold” malignancies, announced that it has received strategic funding from the South Carolina Research Authority (SCRA) and its investment affiliate, SC Launch Inc. The investment will be used to advance the company’s immunotherapy programs toward clinical development and to strengthen its position as a leader in cancer therapeutics.

d-Matrix Raises $275 Million Series C To Accelerate Global AI Inference Expansion

By Amit Chowdhry ● Nov 12, 2025

d-Matrix, a leading developer of generative AI inference compute solutions for data centers, announced the successful closing of a $275 million Series C funding round, valuing the company at $2 billion. This brings the total capital raised to $450 million since its founding in 2019. The new funding will advance the company’s roadmap, accelerate its international expansion, and support large-scale deployments of what d-Matrix describes as the world’s most efficient and highest-performing data center inference platform.

GC AI Raises $60 Million Series B At $555 Million Raised To Empower In-House Legal Teams Worldwide

By Amit Chowdhry ● Nov 12, 2025

GC AI, the rapidly growing AI platform designed specifically for in-house legal teams, has raised $60 million in Series B funding led by Scale Venture Partners and Northzone, with participation from Sound Ventures, Aglaé Ventures, SilverCircle Partners, News Corp, The Council, and strategic investors including Guillermo Rauch, CEO of Vercel. The funding round values the company at $555 million, bringing its total funding to $73 million.

Indivi: CHF15 Million Secured To Advance Biomarker Discovery In Alzheimer’s Drug Development

By Amit Chowdhry ● Nov 12, 2025

Indivi, a Basel-based Tech Bio company specializing in precision medicine for neuroscience, announced the successful closing of a CHF 15 million investment round led by Ava Investors. The new funding will accelerate the validation and deployment of Indivi’s precision medicine tools in early-phase neuroscience drug development, with a specific focus on Alzheimer’s disease.

Meditology Services Acquires CORL To Enhance Healthcare Third-Party Risk Management Capabilities

By Amit Chowdhry ● Nov 12, 2025

Meditology Services, a leading provider of cybersecurity and compliance consulting for the healthcare industry, announced the acquisition of CORL Technologies, a recognized leader in third-party risk management (TPRM) services. The transaction enhances Meditology’s cybersecurity and compliance portfolio with CORL’s data-driven insights, proven TPRM programs, and managed services.

ABN AMRO To Acquire NIBC Bank From Blackstone In €960 Million Deal

By Amit Chowdhry ● Nov 12, 2025

ABN AMRO Bank N.V. announced that it has reached an agreement with Blackstone to acquire NIBC Bank, marking a significant step in strengthening ABN AMRO’s retail and commercial banking presence in the Netherlands.

Attentive.ai: $30.5 Million Series B Raised To Advance AI Innovation In Construction

By Amit Chowdhry ● Nov 12, 2025

Attentive.ai, the San Francisco-based company behind Beam AI, has raised $30.5 million in Series B funding to expand its artificial intelligence capabilities and transform preconstruction workflows across the construction industry. The round was led by global software investor Insight Partners, with additional participation from Vertex Ventures, Tenacity Ventures, and InfoEdge Venture Fund. This new investment brings the company’s total funding to $48 million.

Beside: $32 Million Raised For Bringing AI To The Real Economy

By Amit Chowdhry ● Nov 12, 2025

AI startup Beside has emerged from stealth with a $32 million Series A round, aiming to bridge the gap between artificial intelligence and the real-world professionals who power small and mid-sized businesses. The funding round, led by investors who describe themselves as “on the forefront of AI applications,” marks a significant step toward expanding AI utility beyond enterprise environments and knowledge workers.